Pharmavanty SRL
Pharmavanty reported total assets of 34,846 € at the end of the 2025 financial year (annual accounts filed with the NBB on 31 Aug 2026).
The score of Pharmavanty shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -29 % Total assets -50 %
Accounts of the company itself (not consolidated).
The full file covers 6 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Pharmavanty's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 31 Aug 2026
- Year ended 31 Dec 2024filed on 31 Aug 2025
- Year ended 31 Dec 2023filed on 28 Aug 2024
- Year ended 31 Dec 2022filed on 21 Aug 2023
- Year ended 31 Dec 2021filed on 22 Aug 2022
Pharmavanty's financial analysis
- Solvency82.7%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Pharmavanty
Pharmavanty's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0752.751.474
- VAT number
- BE0752751474
- Peppol
- Registered · 0208:0752751474 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 19 Aug 2020
- Registered office
- 9400 Ninove
- Latest accounts
- 2025 · filed on 31 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Pharmavanty (SRL) has been based in Ninove since 2020, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 25,820 € and equity of 28,820 €; its revenue is not published. Its solvency stands at 82.7%, above the median of its sector (44.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Pharmavanty
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie Pharmiste Retail sale of pharmaceutical products Brussels · balance sheet 57,475 €
- Taxapharm Retail sale of pharmaceutical products Waterloo · balance sheet 35,480 €
- NL Pharma Retail sale of pharmaceutical products Florennes · balance sheet 33,758 €
- Apotheker Silke Christiaens Retail sale of pharmaceutical products Lennik · balance sheet 37,111 €
- VENI Retail sale of pharmaceutical products Meise · balance sheet 32,367 €
- Lorena Boulanger Pharma Retail sale of pharmaceutical products Chapelle-lez-Herlaimont · balance sheet 32,165 €
- PharmAzzy Retail sale of pharmaceutical products Zonhoven · balance sheet 37,787 €
- Goed Aalter Retail sale of pharmaceutical products Anderlecht · balance sheet 31,881 €
Frequently asked questions about Pharmavanty
What is the revenue of Pharmavanty?
Pharmavanty files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Pharmavanty?
In Belgium, the VAT number is the company number prefixed with BE: BE0752751474 for Pharmavanty, if the company is VAT-registered. Its company number (CBE) is 0752.751.474.
Where is the registered office of Pharmavanty?
According to the CBE register, the registered office of Pharmavanty is in 9400 Ninove.
What is the equity of Pharmavanty?
At the close of the 2025 financial year, the equity of Pharmavanty amounts to 28,820 €, a solvency of 82.7% of total assets.
Who manages Pharmavanty?
The register lists 1 active mandates at Pharmavanty. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Pharmavanty
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →